PhRMA Advocates Different FDA "Philosophical Approach" To SUPAC Regs
Executive Summary
PhRMA suggests a different philosophical approach for post-approval manufacturing changes based on performance standards in comments on implementation of FDA Modernization Act section 116 provisions on the topic.